N Faure

No ORCID on file · 4 papers in corpus
rct 1988
Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis
American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(88)90128-7

We have previously reported reversible hypogonadism induced by the intranasal administration of the luteinizing hormone-releasing hormone agonist buserelin as a new therapeutic approach for endometriosis. Thirteen patients were randomized t…

other 1987
LH-RH agonist treatment of endometriosis
Contributions to gynecology and obstetrics
review 1986
Efficacy of different modalities of LHRH agonist (buserelin) administration on the inhibition of the pituitary-ovarian axis for the treatment of endometriosis
Progress in clinical and biological research
other 1984
Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis
Fertility and sterility ·doi:10.1016/s0015-0282(16)47899-4

Ten women with endometriosis (stages I to IV) were treated with twice-daily subcutaneous injections of 200 micrograms of (D-Ser[TBU]6-des-Gly-NH2(10] luteinizing hormone-releasing hormone ethylamide (Buserelin) for 5 days followed by 400 mi…